| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.085 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |